(Q37111972)

18 August 2017

1 reference

title

Health utility values associated with diabetic retinopathy (English)

1 reference

18 August 2017

A Lloyd

1

1 reference

18 August 2017

B Nafees

2

1 reference

18 August 2017

S Gavriel

3

1 reference

18 August 2017

M D Rousculp

4

1 reference

18 August 2017

K S Boye

5

1 reference

18 August 2017

A Ahmad

6

1 reference

18 August 2017

13 March 2008

1 reference

18 August 2017

1 reference

18 August 2017

25

1 reference

18 August 2017

5

1 reference

18 August 2017

618-624

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2008.02430.X

18 August 2017

1 reference

Utility values and diabetic retinopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2008.02430.X

Quality of life associated with visual loss: a time tradeoff utility analysis comparison with medical health states.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2008.02430.X

The influence of diabetic retinopathy on quality of life: interviews to guide the design of a condition-specific, individualised questionnaire: the RetDQoL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2008.02430.X

Utilities associated with diabetic retinopathy: results from a Canadian sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2008.02430.X

The impact of diabetes-related complications on healthcare costs: results from the United Kingdom Prospective Diabetes Study (UKPDS Study No. 65).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2008.02430.X

The association of atherosclerosis, vascular risk factors, and retinopathy in adults with diabetes : the atherosclerosis risk in communities study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2008.02430.X

Estimating utility values for health states of type 2 diabetic patients using the EQ-5D (UKPDS 62).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2008.02430.X

Assessing the impact of visual acuity on quality of life in individuals with type 2 diabetes using the short form-36.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2008.02430.X

TTO utility scores measure quality of life in patients with visual morbidity due to diabetic retinopathy or ARMD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2008.02430.X

Seeing for yourself: feasibility study towards valuing visual impairment using simulation spectacles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2008.02430.X

Modelling EuroQol health-related utility values for diabetic complications from CODE-2 data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2008.02430.X

The impact of diabetic retinopathy: perspectives from patient focus groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2008.02430.X

Variations in population health status: results from a United Kingdom national questionnaire survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2008.02430.X

Utility approach to measuring health-related quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2008.02430.X

Correlates of health-related quality of life in type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2008.02430.X

Assessing the health of the nation. The predictive validity of a preference-based measure and self-rated health

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2008.02430.X

Health utilities in evaluating intervention in the sleep apnoea/hypopnoea syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2008.02430.X

Determinants of health utility in lung and heart-lung transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2008.02430.X

The cost utility analysis of riluzole for the treatment of amyotrophic lateral sclerosis in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2008.02430.X

10.1111/J.1464-5491.2008.02430.X

21 January 2018

Identifiers

DOI

1 reference

18 August 2017

1 reference